Impact of modern radiotherapy on subsequent hematological cancer risk in prostate cancer survivors

被引：0
|
作者：
Jahreiss, M. [1 ]
Aben, K. [2 ]
Bertoen, A. [3 ]
Dirkx, M. [1 ]
Hoogeman, M. [1 ]
Incrocci, L. [1 ]
Nout, R. [1 ]
Heemsbergen, W. [1 ]
机构：
[1] Erasmus MC Canc Inst, Radiotherapy, Rotterdam, Netherlands
[2] Netherlands Comprehens Canc Org, Res & Dev, Utrecht, Netherlands
[3] Univ Appl Sci, Inholland, Haarlem, Netherlands
来源：
RADIOTHERAPY AND ONCOLOGY | 2021年 / 161卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OC-0512
引用
收藏
页码：S395 / S396
页数：2
相关论文
共 50 条
  • [1] Impact of modern radiotherapy on second primary cancer risk in prostate cancer survivors: A nationwide cohort study
    Jahreiss, M-C.
    Heemsbergen, W. D.
    Van Santvoort, B.
    Van Oort, I.
    Hoogeman, M. S.
    Incrocci, L.
    Aben, K. K. H.
    [J]. EUROPEAN UROLOGY, 2021, 79 : S1701 - S1701
  • [2] Impact of Advanced External Beam Radiotherapy on Second Haematological Cancer Risk in Prostate Cancer Survivors
    Jahreiss, M. -c.
    Heemsbergen, W. D.
    Janus, C.
    Pol, M. van de
    Dirkx, M.
    Dinmohamed, A. G.
    Nout, R. A.
    Hoogeman, M.
    Incrocci, L.
    Aben, K. K. H.
    [J]. CLINICAL ONCOLOGY, 2023, 35 (04) : E278 - E288
  • [3] The Risk of Second Primary Cancers in Prostate Cancer Survivors Treated in the Modern Radiotherapy Era
    Jahreiss, Marie-Christina
    Aben, Katja K. H.
    Hoogeman, Mischa S.
    Dirkx, Maarten L. P.
    de Vries, Kim C.
    Incrocci, Luca
    Heemsbergen, Wilma D.
    [J]. FRONTIERS IN ONCOLOGY, 2020, 10
  • [4] Impact of Advanced Radiotherapy on Second Primary Cancer Risk in Prostate Cancer Survivors: A Nationwide Cohort Study
    Jahreiss, Marie-Christina
    Heemsbergen, Wilma D.
    van Santvoort, Bo
    Hoogeman, Mischa
    Dirkx, Maarten
    Pos, Floris J.
    Janssen, Tomas
    Dekker, Andre
    Vanneste, Ben
    Minken, Andre
    Hoekstra, Carel
    Smeenk, Robert J.
    van Oort, Inge M.
    Bangma, Chris H.
    Incrocci, Luca
    Aben, Katja K. H.
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [5] Impact of radiotherapy in the risk of esophageal cancer as subsequent primary cancer following breast cancer
    Salminen, E.
    Pukkala, E.
    Kiel, K.
    Hakulinen, T.
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2007, 183 : 99 - 99
  • [6] Impact of radiotherapy in the risk of esophageal cancer as subsequent primary cancer after breast cancer
    Salminen, Eeva K.
    Pukkala, Eero
    Kiel, Krys D.
    Hakulinen, Timo T.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 65 (03): : 699 - 704
  • [7] Radiotherapy and subsequent thyroid cancer in German childhood cancer survivors
    Spix, C.
    Finke, I.
    Scholz-Kreisel, P.
    Hennewig, U.
    Blettner, M.
    Kaatsch, P.
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2015, 191 (08) : 692 - 692
  • [8] Impact of prostate cancer radiotherapy on the biological behavior and specific mortality of subsequent bladder cancer
    Guo, Xiaoxiao
    Liu, Min
    Hou, Huimin
    Liu, Shenjie
    Zhang, Xianbo
    Zhang, Yaqun
    Wu, Pengjie
    Pang, Cheng
    Wang, Jianye
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2019, 24 (08) : 957 - 965
  • [9] Impact of prostate cancer radiotherapy on the biological behavior and specific mortality of subsequent bladder cancer
    Xiaoxiao Guo
    Min Liu
    Huimin Hou
    Shenjie Liu
    Xianbo Zhang
    Yaqun Zhang
    Pengjie Wu
    Cheng Pang
    Jianye Wang
    [J]. International Journal of Clinical Oncology, 2019, 24 : 957 - 965
  • [10] The impact of dose escalation on secondary cancer risk after radiotherapy of prostate cancer
    Schneider, U
    Lomax, A
    Besserer, J
    Lombriser, N
    Pemler, P
    Ross, D
    Kaser-Hotz, B
    [J]. RADIOTHERAPY AND ONCOLOGY, 2006, 78 : S54 - S54
12345